|
|
Article: Forecast Insight: Insomnia Orexin and Serotonin Receptor Modulators to Innovate Market.
- Article from:
- Business Wire
- Article date:
- October 10, 2008
CopyrightCOPYRIGHT 2008 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/a20453/forecast_insight) has announced the addition of the "Forecast Insight: Insomnia Orexin and Serotonin Receptor Modulators to Innovate Market" report to their offering.
After 3 years of steady growth, the value of the insomnia market across the seven major markets (7MM) slumped by 12% to $4.1 billion in 2007 due to rapid generic erosion of Sanofi-Aventiss market leader Ambien (zolpidem) in the US. However, this downturn will be short-lived and the market will regain growth from 2009 to $6.9 billion in 2017 driven by the launch of new treatments across the 7MM.
Scope ...